$0.65
(Market cap
$4,302 Mln
Recently Viewed
Clear AllMarket cap
$4,302 Mln
Revenue (TTM)
$11,701 Mln
P/E Ratio
--
P/B Ratio
4.4
Div. Yield
0 %
Today’s Range
52 Week Range
Liquidity
Net Profit (TTM)
$0 Mln
ROE
-0.4 %
ROCE
-- %
Industry P/E
--
EV/EBITDA
0
Debt to Equity
0.4
Book Value
$3.5
EPS
$-1.6
Face value
--
Shares outstanding
262,157,000
CFO
$-16.19 Mln
EBITDA
$-2,016.11 Mln
Net Profit
$-2,119.71 Mln
|
Company
|
YTD
|
1 Month
|
3 Months
|
1 Year
|
3 Years
|
5 Years
|
10 Years
|
|---|---|---|---|---|---|---|---|
|
Oscar Health Inc. Class A (OSCR)
| 14.4 | 23.6 | -0.7 | 36.7 | 39.0 | -6.9 | -- |
|
BSE Sensex*
| -6.4 | 6.4 | -3.5 | 0.9 | 10.0 | 10.7 | 11.9 |
|
S&P Small-Cap 600#
| -5.8 | -5.3 | -13.7 | -6.3 | 5.3 | 3.0 | 5.5 |
|
Company
|
2025
|
2024
|
2023
|
2022
|
|---|---|---|---|---|
|
Oscar Health Inc. Class A (OSCR)
| 6.9 | 46.4 | 272.0 | -68.7 |
|
S&P Small-Cap 600
| 4.0 | 7.0 | 13.9 | -17.4 |
|
BSE Sensex
| 9.1 | 8.1 | 18.7 | 4.4 |
Is there a threat to the company's solvency?
Can creative accounting be detected through the financial numbers?
How did the company perform in the last one year?
5Y Avg -- 3Y Avg -- TTM --
P/E Ratio
--
--Min --Median --Max
P/B Ratio
--
--Min --Median --Max
Earnings Yield (%)
--
Earnings Yield (%) = EBIT / Enterprise value
PEG Ratio
--
Price = Price / Earnings to growth ratio
Company |
Price ($) | Market Cap ($ Mln) | Revenue (TTM) | Net Profit (TTM) | OPM (%) | ROE (%) | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
|
Oscar Health Inc. Class A (OSCR)
|
16.4 | 4,302.5 | 11,701.4 | -443.2 | -3.6 | -44.5 | -- | 4.4 |
| 25.8 | 2,421.9 | 1,504.9 | -33.8 | 5.5 | -5.7 | -- | 4.0 | |
| 25.8 | 2,421.9 | 1,504.9 | -33.8 | 0.1 | -5.7 | -- | 4.0 | |
| 61.8 | 3,574.0 | 6,211.0 | 433.0 | -2.9 | 7.4 | 10.9 | 0.5 | |
| 43.9 | 4,113.3 | 4,487.4 | 229.3 | 7.8 | 8.9 | 19 | 1.5 | |
| 26.9 | 12,923.6 | 2,889.0 | -366.0 | 0.4 | -3 | -- | 1.0 | |
| 8.9 | 3,337.3 | 6,367.0 | 223.0 | 5.0 | 2.6 | 15.9 | 0.4 | |
| 44.7 | 1,604.4 | 365.3 | 27.8 | 20.4 | -107.8 | 42.2 | 54.2 | |
| 276.2 | 8,270.2 | 3,226.1 | 751.2 | 30.3 | 31.9 | 11.4 | 3.4 | |
| 37.9 | 9,217.6 | 3,051.1 | 63.4 | 17.0 | 7.3 | 74.2 | 6.7 | |
| 28.9 | 1,224.7 | 1,439.3 | 19.4 | 2.5 | 5.5 | 62.7 | 3.2 |
Oscar Health, Inc. operates as a healthcare technology company in the United States. The company offers health plans to individuals, families, employees, and small group markets. It also provides +Oscar platform that power others throughout the... healthcare system; Campaign Builder platform, an engagement and recommendation platform for providers and payors; and reinsurance products. In addition, the company offers brokerage services and enrollment platform for brokers and consumers to shop, buy, and enroll in medical and supplemental health products. The company was formerly known as Mulberry Health Inc. and changed its name to Oscar Health, Inc. in January 2021. Oscar Health, Inc. was incorporated in 2012 and is headquartered in New York, New York. Address: 75 Varick Street, New York, NY, United States, 10013 Read more
Co-Founder & Vice Chairman
Mr. Joshua Kushner
CEO & Director
Mr. Mark Thomas Bertolini
Headquarters
New York, NY
Website
Our rating system has guided millions of investors in the past 20 years.
The share price of Oscar Health Inc Class A (OSCR) is $16.44 (NYSE) as of 20-Apr-2026 16:27 EDT. Oscar Health Inc Class A (OSCR) has given a return of 39.01% in the last 3 years.
Since, TTM earnings of Oscar Health Inc Class A (OSCR) is negative, P/E ratio is not available.
PE & PB ratio at the end of financial year.
| Year | P/E Ratio | P/B Ratio |
|---|---|---|
|
2025
|
-9.18
|
4.16
|
|
2024
|
140.49
|
3.53
|
|
2023
|
-7.67
|
2.58
|
|
2022
|
-0.87
|
0.59
|
|
2021
|
-2.88
|
1.19
|
The 52-week high and low of Oscar Health Inc Class A (OSCR) are Rs 23.80 and Rs 10.69 as of 21-Apr-2026.
Oscar Health Inc Class A (OSCR) has a market capitalisation of $ 4,302 Mln as on 13-Apr-2026. As per SEBI classification, it is a Small Cap company.
Before investing in Oscar Health Inc Class A (OSCR), assess your goals, risk tolerance, and if the company aligns with your long-term plan. Carefully review its business model, financials, and valuation. Avoid making decisions based on tips or short-term trends.
New Process Alert 
Seems like you've uploaded a wrong QR code. Please upload the QR code downloaded from MF Central platform.